RN7SL1 and neoplasm: RN7SL1 recipient cells, which are T, myeloid, and dendritic cells, activate IFN-dependent inflammatory responses, improving the immunostimulatory effects of dendritic and myeloid cells that end up in activation of CD8 T cells against tumor cells.